Pyxis Oncology
PYXS
PYXS
39 hedge funds and large institutions have $47.7M invested in Pyxis Oncology in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.64M | |
| 2 | +$3.28M | |
| 3 | +$2.3M | |
| 4 |
NM
Newtyn Management
New York
|
+$1.9M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.06M |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$3.42M | |
| 3 | -$3.16M | |
| 4 |
HM
HealthCor Management
New York
|
-$879K |
| 5 |
BlackRock
New York
|
-$752K |